Allogene Therapeutics
ALLO
ALLO
115 hedge funds and large institutions have $1.44B invested in Allogene Therapeutics in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 35 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 116 → 115 (-1)
13% less call options, than puts
Call options by funds: $1.69M | Put options by funds: $1.95M
23% less capital invested
Capital invested by funds: $1.86B → $1.44B (-$425M)
Holders
115
Holding in Top 10
5
Calls
$1.69M
Puts
$1.95M
Top Buyers
| 1 | +$47.2M | |
| 2 | +$13.4M | |
| 3 | +$9.72M | |
| 4 |
JP Morgan Chase
New York
|
+$5.9M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$4.86M |
Top Sellers
| 1 | -$25.1M | |
| 2 | -$15.9M | |
| 3 | -$11.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.17M |
| 5 |
D.E. Shaw & Co
New York
|
-$3.25M |